ATE212129T1 - Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle - Google Patents

Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle

Info

Publication number
ATE212129T1
ATE212129T1 AT95941326T AT95941326T ATE212129T1 AT E212129 T1 ATE212129 T1 AT E212129T1 AT 95941326 T AT95941326 T AT 95941326T AT 95941326 T AT95941326 T AT 95941326T AT E212129 T1 ATE212129 T1 AT E212129T1
Authority
AT
Austria
Prior art keywords
methods
antigens
lam
cells
presented
Prior art date
Application number
AT95941326T
Other languages
English (en)
Inventor
Robert L Modlin
Peter A Sieling
Michael B Brenner
Patrick J Brennan
Steven A Porcelli
Stephen T Furlong
Original Assignee
Brigham & Womens Hospital
Univ California Los Angeles
Univ Colorado State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/322,979 external-priority patent/US5853737A/en
Priority claimed from US08/322,980 external-priority patent/US5679347A/en
Priority claimed from US08/501,600 external-priority patent/US6238676B1/en
Application filed by Brigham & Womens Hospital, Univ California Los Angeles, Univ Colorado State Res Found filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of ATE212129T1 publication Critical patent/ATE212129T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Peptides Or Proteins (AREA)
AT95941326T 1994-10-13 1995-10-13 Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle ATE212129T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/322,979 US5853737A (en) 1992-12-10 1994-10-13 Method for inducing a CD1-restricted immune response
US08/322,980 US5679347A (en) 1992-12-10 1994-10-13 Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US50149195A 1995-07-12 1995-07-12
US08/501,600 US6238676B1 (en) 1992-12-10 1995-07-12 Presentation of hydrophobic antigens to T-cells by CD1 molecules
PCT/US1995/013274 WO1996012190A2 (en) 1994-10-13 1995-10-13 Presentation of hydrophobic antigens to t-cells by cd1 molecules

Publications (1)

Publication Number Publication Date
ATE212129T1 true ATE212129T1 (de) 2002-02-15

Family

ID=27502254

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941326T ATE212129T1 (de) 1994-10-13 1995-10-13 Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle

Country Status (7)

Country Link
EP (2) EP0786088B1 (de)
JP (1) JPH10510142A (de)
AT (1) ATE212129T1 (de)
AU (1) AU694299B2 (de)
CA (1) CA2202680A1 (de)
DE (1) DE69525058D1 (de)
WO (1) WO1996012190A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238676B1 (en) 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
JPH09512101A (ja) * 1994-04-14 1997-12-02 アドコック、イングラム、リミテッド Ｍｙｃｏｂａｃｔｅｒｉｕｍ種の存在の検出法およびその方法に用いられるキットおよび抗体
EP1011719A1 (de) * 1997-09-12 2000-06-28 Brigham & Women's Hospital Synthetische antigene zur cd-1 beschränkte immunantwort
CA2323733A1 (en) * 1998-04-13 1999-10-21 Michael B. Brenner Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
US20020071842A1 (en) * 2000-06-05 2002-06-13 Gumperz Jenny E. Soluble CD1 compositions and uses thereof
FR2819724B1 (fr) * 2001-01-22 2005-05-13 Inst Necker Moyens pour induire une reponse immune aux antigenes bacteriens polysccharidiques et aux structures proteiques des capsides de virus
WO2004093903A2 (en) 2003-04-18 2004-11-04 The Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation using cd1 antigens
GB0708874D0 (en) * 2007-05-08 2007-06-13 Univ The Of Birmingham Assay for detecting mycrobacterial infection
CN112805369A (zh) 2018-08-08 2021-05-14 南特生物公司 重组cd1限制性t细胞及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014155A1 (en) * 1991-02-12 1992-08-20 Dynagen, Inc. Monoclonal antibodies directed towards mycobacterial antigens
AU1564592A (en) * 1991-02-12 1992-09-07 Dynagen, Inc. Agglutination test for mycobacterial antigens in biological samples
DK0751780T3 (da) * 1993-06-21 2003-10-13 Brigham & Womens Hospital Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder

Also Published As

Publication number Publication date
EP0786088B1 (de) 2002-01-16
JPH10510142A (ja) 1998-10-06
WO1996012190A3 (en) 1996-06-27
CA2202680A1 (en) 1996-04-25
WO1996012190A2 (en) 1996-04-25
AU4277996A (en) 1996-05-06
EP1170592A1 (de) 2002-01-09
DE69525058D1 (de) 2002-02-21
AU694299B2 (en) 1998-07-16
EP0786088A2 (de) 1997-07-30

Similar Documents

Publication Publication Date Title
DK0941478T4 (da) Assaymetode for peptidspecifikke T-celler
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
PT807178E (pt) Proteinas de micobacterias, microrganismos que as produzem e suas utilizacoes vacinicas e para a deteccao da tuberculose
NO924780L (no) Ekspresjon av spesifikke immunogener ved bruk av virusantigener
ES2116719T3 (es) Dispositivo de analisis de flujo interrumpido.
FI913560A0 (fi) Syntetiska peptider, speciellt foer observation av hcv-anti-kroppar, hcv-infektionsdiagnos och dess foerhindrande sm vaccin.
DE69525058D1 (de) Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle
ES2170152T3 (es) Virus de la hepatitis g y clon molecular del mismo.
NO20024571D0 (no) Immunoterapeutiske fremgangsmåter og blandinger
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
AU525403B2 (en) Purified antigen
DE69515340D1 (de) Impfstoff gegen mycobakterielle infektionen
ATE445839T1 (de) Latentes tuberkulose-diagnostisches antigen und verwendungsmethode
DE69520108D1 (de) Testverfahren
DK0751780T3 (da) Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder
KR930008462A (ko) 치주질환과 관련된 미생물의 검증방법에서 높은 pH에서의 추출로 단백질을 보호하는 용도 및 이에 유용한 키트
DK0815451T3 (da) Fremgangsmåde til undersøgelse af husstøv og anvendelse af et detekteringsmiddel
BR9507389A (pt) Método para detectar a presença de uma espécie mycobacterium e um kit e anticorpos para uso no mesmo
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
DE60327544D1 (de) Gentechnisch hergestelltes p30-antigen, verbesserter antigen-cocktail und verwendungen davon
ATE403867T1 (de) Evaluierung adjuvanshaltiger impfstoffe
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
ATE270345T1 (de) Nukleinsaeure erkennung von hepatitis gb virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties